Symbios Technologies LLC. Industries
-
Pharmaceuticals
-
-
Medical / Health Care
-
Pharmaceutical manufacturers seek improved, lower-cost oxidation methods for ultrapure process water and to remove organics in produced water applications. The Symbios TPR4000™ can provide lower cost, higher performance, more effective disinfection, reduce RO fouling & costs, and reduce post-MBR odor/residual organics when compared to traditional treatment methods that include chemical additives.
The Symbios TPR4000™ has great promise in the field of healthcare beyond its obvious benefits in the manufacture of pharmaceuticals and the treatment of the waste stream that results from the manufacturing process. While these healthcare applications will likely require an FDA approval process, Symbios is partnering with leaders in their respective fields to navigate through the required regulatory approval process.